Type 2 diabetes mellitus in combination with sarcopenia or possible sarcopenia
Conditions
Interventions
Control group:Maintain existing medical management without specific remote multidimensional interventions.
intervention group:Receive a 12-week remote multidimensional comprehensive intervention program that included medical guidance, exercise intervention, nutritional intervention, health education, self-
Sponsors
Department of Endocrinology, Peking University First Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. patients who have completed the registration of initial diagnosis and regular follow-up in the diabetes co-care management cohort of Peking University First Hospital; 2. patients with type 2 diabetes; 3. age > 18 years old; 4. conscious and able to answer questions independently; 5. participate voluntarily in this study; 6. can participate in the intervention trial with the consent of their physician; 7. (Also required for the intervention study) meet any of the following: a. When using a spring-loaded grip strength meter to measure the grip strength of the upper limbs, when the grip strength is <28kg for males and <18kg for females it is considered to be a decrease in muscular strength; b. Physical functioning is assessed using the five-stand-up time, and a five-stand-up time of =12 seconds is considered to be a decrease in physical fitness.
Exclusion criteria
Exclusion criteria: 1. the presence of severe visual or hearing impairments or communication disorders; 2. the presence of cognitive dysfunction or mental retardation; 3. the presence of a terminal illness with a life expectancy of = 6 months; 4. the presence of serious concomitant diseases such as heart, brain, kidney, etc. that prevent them from cooperating with the intervention; 5. the presence of joint pain, fractures and other contraindications to exercise; 6. concurrent participation in other studies. 7. pre-diabetes, type 1 diabetes, special type of diabetes and other non-type 2 diabetes patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Handgrip strength;Bioelectrical impedance analysis;5-time chair stand test;10-second heel lifts; | — |
Secondary
| Measure | Time frame |
|---|---|
| Height;Weight;waist circumference;Hip measurement;calf circumference;stand on both legs with closed eyes;stand on one leg with open eyes;Quality of Life Assessment Scale SF-36; | — |
Countries
China
Contacts
Public ContactLi Ang
Peking University First Hospital
Outcome results
None listed